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Abstract
Brassinosteroids (BRs) are plant steroid hormones that control many aspects of plant growth and 
development. BRs are perceived at the cell-surface by the plasma membrane-localized receptor 
complex composed of the receptor kinase BRI1 and its co-receptor BAK1. Here we show that 
BRI1 is post-translationally modified by K63 polyubiquitin chains in vivo. Artificially 
ubiquitinated BRI1 is recognized at the trans-Golgi Network/Early Endosomes (TGN/EE) and 
rapidly routed for vacuolar degradation. Mass spectrometry analyses identified residue K866 as an 
in vivo ubiquitination target in BRI1 involved in the negative regulation of BRI1. Model 
prediction revealed several redundant ubiquitination sites required for the endosomal sorting and 
vacuolar targeting of BRI1. Using total internal reflection fluorescence microscopy (TIRF), we 
also uncovered a role for BRI1 ubiquitination in promoting internalization from the cell-surface. 
Finally, we demonstrate that the control of BRI1 protein dynamics by ubiquitination is a 
fundamental control mechanism for BR responses in plants. Altogether, our results identify K63-
linked polyubiquitin chain formation as a dual targeting signal for BRI1 internalization and sorting 
along the endocytic pathway, and highlight its role in hormonally controlled plant development.
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Introduction
Brassinosteroids (BRs) are polyhydroxylated plant steroid hormones that regulate plant 
growth and development 1. Studies of mutants with defects in BR biosynthesis or signaling 
demonstrated that BRs play essential roles in nearly all phases of plant development, as 
these mutants show multiple developmental defects, such as reduced seed germination, 
extreme dwarfism, photomorphogenesis in the dark, altered distribution of stomata, delayed 
flowering and male sterility 1, 2. BRs are perceived at the cell surface by the membrane-
bound receptor complex composed of the BRASSINOSTEROID INSENSITIVE1 (BRI1) 
receptor kinase and BRI1-ASSOCIATED RECEPTOR KINASE1 (BAK1) 3, 4, 5. Ligand-
dependent auto- and trans- phosphorylation of BRI1 and BAK1 participate in receptor 
complex activation and modulate a cellular cascade of kinases and phosphatases 6, 7, which 
ultimately culminates in the dephosphorylation and activation of two transcription factors, 
BRASSINAZOLE-RESISTANT1 (BZR1) and BRI1-EMS SUPPRESSOR1 (BES1) 8, 9. 
BES1 and BZR1 bind to target promoters in the presence of different interacting partners to 
regulate BR genomic responses 10, 11, 12.
Adjustments in subcellular distribution of cell surface receptors are critical to modulate their 
signaling activity. Over the past decade, BRI1 has served as model for a better 
understanding of the interplay between receptor trafficking, signal transduction and 
deactivation. BRI1 constitutively cycles between the plasma membrane and the trans-Golgi 
network/early endosome (TGN/EE), and it is targeted to the vacuole for degradation via the 
late endosomes/multivesicular bodies (MVBs), independently of its ligand 13, 14. The drug-
mediated trapping of BRI1 in endosomes was shown to enhance BR responses, leading to a 
model whereby BRI1 signals preferentially from endosomal compartments 13. This concept 
was recently challenged by novel genetic or pharmacological interferences of BRI1 
internalization mechanisms from the cell surface. Blocking BRI1 internalization was shown 
to activate BR signaling, indicating that BRI1 signals from the plasma membrane 15, 16. 
These mechanisms include clathrin-mediated endocytosis, the adaptor complex AP-2 and 
the ARF-GEFs GNOM and GNL1 15, 16.
The post-translational modification of proteins by ubiquitination is well-known in yeast and 
mammals to target proteins to proteasome-mediated degradation. Ubiquitination also serves 
numerous proteasome-independent roles, including the endocytosis of membrane 
proteins 17. In plants, Ub-mediated endocytosis emerged only very recently with the study of 
ion and hormone transporters 18, 19, 20, 21, 22. Whether Ub-mediated endocytosis has also 
been co-opted for driving the trafficking of receptors is unclear. Although several plant E3 
ubiquitin ligases have been shown to interact with receptors 23, 24, 25, 26, their direct role in 
receptor ubiquitination has not been shown. Only the ubiquitination of the cell-surface 
flagellin receptor FLS2 by the PUB12 and PUB13 E3 ligases targets has been 
experimentally demonstrated, but linked to proteasomal degradation of FLS2 27.
Here we demonstrate that BRI1 is post-translationally modified by K63 polyubiquitin chains 
in vivo. Artificial ubiquitination of BRI1 negatively regulates its activity by enhanced 
vacuolar targeting from EE/TGN and degradation in the vacuole. Mass spectrometry 
analyses identified residue K866 of BRI1 as a target of ubiquitination in vivo. Loss of BRI1 
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ubiquitination at residue K866 is associated with subtle BR hypersensitivity phenotypes, 
confirming the negative role played by BRI1 ubiquitination on BR signaling, and pointing to 
the existence of other ubiquitination sites in BRI1. Model-based prediction of cell surface-
exposed lysine residues in BRI1 allowed the generation of a functional but non-
ubiquitinatable mutant of BRI1 (BRI1K25R). Global loss of BRI1 ubiquitination is associated 
with major defects in endosomal sorting and vacuolar delivery. Using Total Internal 
Reflection Fluorescence Microscopy (TIRF-M), we also shed light on the role of BRI1 
ubiquitination in the internalization of BRI1 from the cell-surface. In addition, we establish 
that the control of BRI1 protein dynamics by ubiquitination is a fundamental control 
mechanism for BR responses in plants. Altogether, our results identify K63-linked 
polyubiquitin chain formation as a dual targeting signal for BRI1 internalization and sorting 
along the endocytic pathway, and uncovered its role in hormonally controlled plant 
development.
Results
BRI1 receptor is ubiquitinated in vivo
Earlier work demonstrated that BRI1 undergoes endocytosis and trafficking to the vacuole, 
independently of its activation state 13. However, little is known about the mechanisms 
driving BRI1 protein dynamics in the cell. Ubiquitination of cell-surface receptors in yeast 
and mammals has been shown to control internalization and/or vacuolar/lysosomal 
targeting 17. To determine if BRI1 carries ubiquitin moieties in vivo, we used anti-GFP 
antibodies to immunopreciptate BRI1 from bri1 mutants complemented by the expression of 
the functional BRI1::BRI1-mCitrine protein 28. Similar experiments were performed in 
parallel in wild-type backgrounds as controls. Immunoprecipitates from BRI1-mCitrine-
expressing plants were enriched in BRI1-mCitrine, as attested by the strong signal observed 
at the expected size of BRI1-mCitrine fusion protein (~170 kDa; Fig. 1a, left panel). To 
evaluate if a fraction of BRI1 is post-translationally modified by ubiquitination, 
immunoprecipitates were probed with the general P4D1 anti-Ubiquitin antibodies that 
recognizes monoubiquitin and several forms of polyubiquitin chains. A high molecular 
weight smear, typical of ubiquitinated proteins, was specifically observed from ~170kDa in 
immunoprecipitates from BRI1::BRI1-mCitrine plants (Fig.1a, middle panel). A comparable 
high molecular weight smear was observed when using the Apu3 K63 polyubiquitin chain-
specific antibody, indicating that BRI1 is decorated by K63 polyubiquitin chains in vivo 
(Fig. 1a, right panel).
We next addressed whether ubiquitination of BRI1 was regulated by steroid hormone 
perception. Challenging plants for 1 hour with 1μM brassinolide (BL), the most active 
brassinosteroid form, to BRI1-mCitrine plants had no detectable effect on the ubiquitination 
profile of BRI1-mCitrine (Fig. 1b). It is possible that such young growing BRI1-mCitrine 
plants have close to maximal levels of activated receptors, thus preventing the detection of 
ligand-dependent changes in BRI1 ubiquitination. However, two lines of evidence argue 
against this hypothesis. First, BRI1-mCitrine plants are fully responsive to exogenously 
applied BL, as observed by the marked change in BES1 phosphorylation status (Fig. S1a), 
indicating that BR responses are not saturated. Second, growing plants on the BR 
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biosynthetic inhibitor brassinazole (BRZ) prior to BL treatment had minor effect on BRI1 
ubiquitination (Fig. S1b). These observations contrast with the dramatic ubiquitination 
underwent by the mammalian Epidermal Growth Factor Receptor (EGFR) upon few minutes 
of EGF exposure 29, a typical example of ligand-induced receptor ubiquitination. Taken 
together, these observations indicate that BRI1 ubiquitination is largely not regulated by 
ligand binding to the receptor. They also concur perfectly with the earlier findings that BRI1 
trafficking and degradation are ligand-independent 13.
Mechanism of BRI1 ubiquitination
We next investigated the molecular mechanisms driving BRI1 ubiquitination. In particular, 
we focused on the possible role played by receptor activation, although BRI1 ubiquitination 
appears to be independent of ligand binding (Fig. 1b). Lysine residue K911 of BRI1 is an 
invariant residue in subdomain II of kinases and is critical for BRI1 kinase activity and BR 
signaling. Consequently, bri1 mutant expressing the kinase-dead K911R mutation are not 
complemented and show extreme dwarfism 30. Transgenic plants expressing the non-
functional BRI1K911R mutant form under the control of BRI1 promoter were assayed for 
BRI1 ubiquitination. In contrast to what is observed in the wild-type form of BRI1, 
BRI1K911R-expressing plants showed reduced ubiquitination (Fig. 1c). This suggests that 
BRI1 kinase activity is required for ubiquitination. The possibility that residue K911 itself is 
a major ubiquitination site in BRI1 protein is very unlikely since it is not surface-exposed 
(Fig. S4a). Mutation in K911 of BRI1 was showed to drastically affect BRI1-BAK1 receptor 
complex formation 31. We therefore addressed whether the co-receptor BAK1 was required 
for BRI1 ubiquitination. To this purpose, we expressed BRI1::BRI1-mCitrine in a bak1 null 
mutant background. Compared to wild-type BRI1::BRI1-mCitrine plants, bak1-3/
BRI1::BRI1-mCitrine showed a reduction in BRI1 ubiquitination (Fig. 1c). Altogether, these 
results indicate that although BRI1 ubiquitination is not stimulated by steroid perception, it 
is dependent on BRI1 kinase activity and its co-receptor BAK1, two hallmarks of ligand 
perception by BRI1 1.
Artificial ubiquitination of BRI1 triggers rapid endocytosis and vacuolar targeting
Extensive work in yeast and mammals demonstrated the importance of K63 
polyubiquitination for plasma membrane protein internalization, and sorting in 
multivesicular bodies 32. However, K63 polyubiquitination has also been involved in the 
regulation of kinases. TAK1 (transforming growth factor-β activating kinase 1) mediates 
NF-κB activation in response to the activation of TGF-β receptor. Upon stimulation with 
TGF-β, TAK1 undergoes TRAF6-dependent K63-linked ubiquitination on residue K34. 
Modification of TAK1 by ubiquitination is critical for TAK1 autophosphorylation and 
subsequent activation 33. To get a first glimpse into the biological role of BRI1 post-
translational modification by K63 polyubiquitination, we took a gain-of-function approach 
where BRI1-mCitrine was translationally fused to Ub. We used the complementation of the 
dwarfism of bri1 null mutant as readout for BRI1 activity (Fig. S2a). As controls, we also 
generated bri1/BRI1-mCitrine, as well as bri1/BRI1-mCitrine-UbI44A carrying a point 
mutation in a hydrophobic patch necessary for recognition by ubiquitin-binding domain 
proteins 34. Both bri1/BRI1-mCitrine and bri1/BRI1-mCitrine-UbI44A, expressing a non-
functional ubiquitin, fully complemented the severe dwarfism of bri1 null mutant (Fig. 2a). 
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In contrast, BRI1::BRI1-mCitrine-Ub hardly complemented bri1 phenotype, indicating that 
artificial ubiquitination of BRI1 down-regulates its activity. Care was taken at that stage to 
use transgenic lines expressing similar amounts of RNA for the transgene (Fig. S2b). 
Artificial ubiquitination of BRI1-mCitrine protein led to a strong decrease in total BRI1-
mCitrine protein levels compared to wild-type BRI1-mCitrine and BRI1-mCitrine-UbI44A 
(Fig. 2b). This is consistent with confocal microscopy observations where BRI1-mCitrine-
Ub failed to accumulate with the same detection settings used for BRI1-mCitrine (Fig. 2c). 
Higher laser intensity and gain however revealed a punctate pattern for BRI1-mCitrine-Ub, 
with little or no accumulation at the plasma membrane (Fig. 2c inset). These observations 
indicate that ubiquitination of BRI1 is sufficient to trigger its degradation.
To investigate deeper the mechanisms driving the loss of BRI1-mCitrine-Ub protein, we 
took advantage of drugs interfering with vesicular trafficking. The fungal toxin Brefeldin A 
(BFA) is a widely used inhibitor of endosomal trafficking, creating large aggregates of 
trans-Golgi network/early endosomal compartments. Although BRI1-mCitrine-Ub failed to 
accumulate under normal conditions, BRI1-mCitrine-Ub levels rapidly built up in BFA 
bodies after BFA treatment (Fig. 2d). This suggests that BRI1-mCitrine-Ub exits the 
endoplasmic reticulum and passes though the TGN/EE on its way to degradation. We next 
assessed the influence of the vacuolar ATPase inhibitor Concanamycin A (ConA), which 
prevents the degradation of proteins targeted to the vacuole. ConA treatment led to the 
dramatic accumulation of BRI1-mCitrine-Ub in the vacuole (Fig. 2d), compared to BRI1-
mCitrine, thus revealing enhanced vacuolar delivery triggered by ubiquitin. This indicates 
that artificial ubiquitination of BRI1-mCitrine is sufficient for vacuolar targeting.
We next investigated whether BRI1-mCitrine-Ub was trafficking via the plasma membrane 
on its way to the vacuole by inhibiting clathrin-mediated endocytosis, the major endocytic 
road in plants 35. TyrA23 treatment was ineffective at stabilizing BRI1-mCitrine-Ub at the 
cell surface, but rather led to a cytosolic-like pattern of fluorescence (Fig. S2c). In contrast, 
TyrA23 prevented the formation of BFA bodies in BRI1-mCitrine plants (Fig. S2d), 
attesting that TyrA23 treatment was active. Taken together, these results indicate that 
artificial ubiquitination is recognized at the TGN/EE and serves as a targeting signal for 
degradation in the vacuole.
BRI1 is ubiquitinated at residue K866 in vivo
To identify ubiquitination sites in BRI1, we performed immunoprecipitation of BRI1 in the 
presence of deubiquitinase inhibitors followed by mass spectrometry analyses. 
Immunopurified BRI1-mCitrine was digested by trypsin and subjected to liquid-
chromatography tandem mass spectrometry analyses (LC-MS/MS). Multidimensional 
Protein Identification Technology (MudPIT) analyses on BRI1-mCitrine 
immunoprecipitates detected 9 BRI1 peptides, including the EALSINLAAFEKGGPLR 
peptide modified by the tryptic ubiquitin remnant G-G isopeptide on the lysine residue 
K866. This residue lies on the cytosolic face of BRI1 protein, in the juxtamembrane domain 
(Fig. 3a). To examine the biological role of K866 ubiquitination, we generated the bri1/
BRI1::BRI1K866R-mCitrine where K866 is substituted to the positively charged but non-
ubiquitinatable R residue. bri1/BRI1::BRI1K866R-mCitrine transgenic plants expressing 
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similar BRI1-mCitrine levels than bri1/BRI1::BRI1-mCitrine possessed slightly more 
dephosphorylated BES1 (Fig. 3b), a hallmark of active BR signaling. Although bri1/
BRI1::BRI1K866R-mCitrine plants displayed a wild-type phenotype at the rosette stage (Fig. 
3c), such plants showed slightly longer hypocotyls when grown under both normal 
conditions and BRZ (Fig. 3d). This latter observation is consistent with BRI1 ubiquitination 
being largely independent on the ligand (Fig. 1b). No striking difference on the localization 
and the levels of BRI1K866R-mCitrine protein could be observed, however (Fig. 3e). 
Altogether, ubiquitination of residue K866 appears to play a negative role on BRI1 activity. 
Nevertheless, it is clear from the mild BR-related phenotypes displayed by bri1/
BRI1::BRI1K866R-mCitrine transgenic plants, and from its ubiquitination profile still 
harboring massive ubiquitination (Fig. S3), that many more ubiquitination sites are expected 
in BRI1 protein.
Loss of BRI1 ubiquitination impairs both internalization and vacuolar targeting
The intracellular domain of BRI1 contains 29 lysine residues. Sequence alignment of BRI1 
with i) the BRLs BRI1 homologs from Arabidopsis, ii) BRI1 from other species, iii) 
Arabidopsis receptor kinases belonging to different subfamilies (FLS2, CLV1) and iv) 
human IRAK4 indicate that four lysines are highly conserved in BRI1 kinase. These include 
the ATP-binding pocket-located K899, K911 and K912, and residue K1011 in the catalytic 
loop. Model prediction for BRI1 kinase domain, based on the structure of hsIRAK4 
indicates that most other lysine residues are either surface exposed or close to the surface 
and potentially accessible for post-translational modification (Fig. S4a). To pinpoint the role 
of BRI1 ubiquitination, we mutated 25 lysines to arginines and conserved only the four 
conserved lysine residues required for kinase activity. Strikingly, expression of the resulting 
BRI1K25R mutants complemented the dwarf phenotype of bri1 null mutant (Fig. 4a). This 
result indicates that BRI1K25R-mCitrine was still functional and that none of these 25 lysines 
are required for receptor activation. However, BRI1K25R-mCitrine ubiquitination was 
reduced compared to BRI1-mCitrine (Fig. S4b). Interestingly, BRI1K25R-expressing plants 
showed long bending petioles and narrow leaf blades (Fig. 4b), reminiscent of what is 
observed in BRI1-overexpressors 36. The BR hypersensitivity phenotype of BRI1K25R is 
observed even when plants express less BRI1 proteins than bri1/BRI1-mCitrine plants (Fig. 
4c), highlighting further the negative role played by ubiquitination on BRI1 activity.
BRI1 protein is found under normal conditions at the plasma membrane, but also in 
endosomal compartments (TGN/EE and MVB) (Fig. 4d) 13, 14. In contrast, BRI1K25R-
mCitrine was found mostly at the cell-surface with little intracellular compartments 
observed. To unravel the mechanism leading to more BRI1K25R-mCitrine being found at the 
plasma membrane, we compared the endocytic trafficking of BRI1-mCitrine and BRI1K25R-
mCitrine. BFA inhibits the trafficking of membrane proteins from TGN/EEs to MVBs and 
recycling to the plasma membrane, but allows endocytosis. Both BRI1-mCitrine and 
BRI1K25R-mCitrine accumulated in BFA compartments in absence of de novo protein 
synthesis (Fig. 4e). This suggests that BRI1K25R-mCitrine still underwent internalization 
from the plasma membrane. To obtain more resolution and quantitative data on the 
dynamics of BRI1 and BRI1K25R at the cell surface, we implemented Total Internal 
Reflection Fluorescence microscopy (TIRF). TIRF generates high contrast images and 
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allows studying the dynamic behavior of proteins at the plasma membrane. BRI1-mCitrine-
expressing plants were imaged by TIRF microscopy over time and showed small diffraction-
limited fluorescent spots (Movie S1, S2). These spots were immobile on the (x,y) axis but 
dynamically appeared and disappeared from the focal plane, thus representing fusion and 
fission events at the cell surface. A similar pattern was observed for BRI1K25R-mCitrine, 
although the density of spots at the cell surface was higher (Fig. S4c). To grasp the role of 
ubiquitination in BRI1 internalization from the plasma membrane, we further analyzed the 
dynamic behavior of wild-type BRI1 and BRI1K25R by kymograph analysis. Kymographs 
monitor on a single image the intensity at a given (x,y) location over time, and allow 
determination of surface time residence for wild-type BRI1 and its non-ubiquitinatable 
counterpart by measuring track length (Fig. 4f). The time of residency of BRI1-mCitrine at 
the cell surface was widely distributed (Fig. 4g), but over 60% of the spots resided less than 
10s at the plasma membrane. The distribution observed for BRI1K25R was markedly 
different, with most spots persisting longer at the plasma membrane. The surface residence 
time median values for BRI1 and BRI1K25R were 7.2s and 28.6s, respectively (Fig. S4d). 
These observations clearly argue for a direct role of BRI1 ubiquitination in internalization of 
the plasma membrane.
We next monitored the role of ubiquitination in BRI1 vacuolar targeting. BRI1-mCitrine and 
BRI1K25R-mCitrine were transferred to dark conditions, which impair vacuolar lytic activity 
and allow visualization of fluorescent fusion proteins targeted to the vacuole, and monitored 
by confocal microscopy. Consistently, BRI1-mCitrine showed vacuolar accumulation after 2 
hours of darkness (Fig. 4h). However, BRI1K25R-mCitrine exhibited no vacuolar targeting 
within the same time frame. Altogether, our results demonstrate that BRI1 ubiquitination 
plays a role in BRI1 receptor internalization from the plasma membrane and also acts on its 
endosomal sorting and vacuolar targeting.
Discussion
The BR receptor BRI1 is the best-studied plant receptor and serves as the archetypical 
receptor to study the activation/deactivation mechanisms involved in receptor-mediated 
signaling. Previous studies have shed light on the ligand-dependent oligomerization and 
phosphorylation of the BRI1/BAK1 receptor complex and have identified components of the 
BR signaling pathway controlling BR genomic responses 37. However, not much is known 
about the mechanisms driving the trafficking of BRI1 and its turnover in relationship with 
signaling. In this report, we show that BRI1 dynamics in the cell is controlled by K63 
polyubiquitination and unravel its crucial role for BR-mediated plant growth.
Ubiquitination of proteins has been associated with many different cellular outputs in yeast 
and mammals, depending on the type of ubiquitination 32. In the case of membrane proteins, 
ubiquitination triggers endocytosis and vacuolar/lysosomal degradation 17. In plants, only a 
handful of integral membrane proteins have been shown to undergo Ub-mediated 
endocytosis. These examples are so far exclusively restricted to multispan transporters 
involved in iron, boron or phosphate nutrition or in auxin transport 18, 19, 20, 21. Both 
monoubiquitination and K63 polyubqiuitination has been implicated in these examples, 
consistent with their described roles in yeast and mammals. Ubiquitination of plant receptors 
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is still poorly documented, although several E3-Ub ligases interacting with receptors have 
been identified 23, 24, 25, 26. The Flagellin receptor FLS2 involved in plant immune responses 
have been shown to be ubiquitinated by K48 polyubiquitin chains and degraded by the 
proteasome 27. Using a gain-of-function approach, we demonstrated that the artificial 
ubiquitination of BRI1 is sufficient for destabilizing the corresponding protein (Fig. 2a). 
Destabilization of BRI1-mCitrine-Ub protein involves trafficking through the TGN/EE and 
degradation in the vacuole, based on the strong accumulation of BRI1-mCitrine-Ub 
following treatments with BFA and ConcA. Inhibition of clathrin-mediated endocytosis, the 
major BRI1 endocytic route 15, 16, with TyrA23 failed to stabilize BRI1-mCitrine-Ub at the 
cell-surface (Fig. S2d), suggesting that the ubiquitinated BRI1 variant never reaches the 
surface. Formally, artificially ubiquitinated BRI1 could be rapidly endocytosed from the 
plasma membrane using a clathrin-independent pathway, we favor the hypothesis that BRI1-
mCitrine-Ub is recognized at the TGN/EE and diverted away from the secretory pathway 
before it reaches the plasma membrane, being directly routed to the vacuole for degradation. 
The sorting and vacuolar/lysosomal targeting of ubiquitinated cargos in yeast and mammals 
require the late endosome-located ESCRT complex 17. In plants, several subunits of the 
ESCRT complex have been detected in TGN/EE 38, indicating that the sorting of 
ubiquitinated cargos and BRI1-mCitrine indeed occurs already at the TGN/EE. The 
combination of ubiquitination site identification by mass spectrometry and model-based 
prediction allowed us to generate a functional ubiquitination-defective BRI1K25R mutant 
form. In contrast to wild-type BRI1 that shows significant endosomal localization 13, 
BRI1K25R was mostly found at the cell surface (Fig. 4d). Besides residue K866, BRI1 
carries several redundant ubiquitination sites although their precise location is not defined. 
Detailed analysis of BRI1K25R trafficking revealed its inability to reach the vacuole under 
dark condition (Fig. 4h), clearly demonstrating that BRI1 ubiquitination plays critical 
proteasome-independent roles by driving vacuolar targeting. These observations are in 
accordance with the enhanced vacuolar delivery of artificially ubiquitinated BRI1-mCitrine-
Ub (Fig. 2d) and with what has been reported previously for EGFR 39.
The fact that BRI1-mCitrine-Ub is sorting at TGN/EE before reaching the cell-surface 
prevents us from investigating the role of ubiquitination in internalization of BRI1 from the 
plasma membrane. To circumvent this limitation, we implemented TIRF microscopy to 
specifically monitor BRI1 dynamics at the cell surface. Such analysis first highlighted the 
highly dynamic behavior of wild-type BRI1, with extremely rapid fusion and fission events 
within the seconds range (Fig. 4f, movies S1, S2). This fast mode of endocytosis and 
recycling resemble “kiss and run” models in which the vesicle opens and closes transiently, 
as described for synaptic vesicles 40. Interestingly, BRI1K25R shows much slower fusion/
fission events at the plasma membrane, within the tens of second range (Fig. 4f). 
Ubiquitination of BRI1 therefore appears as one mechanism of BRI1 internalizing from the 
plasma membrane, although Ub-independent mechanisms are at stake in contrast to the 
fundamental role of Ub in endosomal sorting. Slower internalization and recycling caused 
by the vacuolar targeting defect could be the basis of increased BRI1K25R at the cell surface 
and increased spot density. This scenario is reminiscent of what is currently debated for the 
Epidermal Growth Factor Receptor (EGFR) in animals. Inhibition of ubiquitination by 
mutating 15 ubiquitin conjugation sites found in the EGFR kinase domain or the Cbl E3 
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ligase-binding site does not affect internalization, although preventing lysosomal 
degradation 39. EGFR internalization from the cell surface is impaired only when 21 lysine 
residues in the kinase domain and C-terminal domain are mutated, although the three distal 
lysines in the C-terminal domain appeared to be acetylated 41. EGFR internalization is 
dependent on many redundant lysine residues and involves several redundant and 
cooperative mechanisms 41.
Modification of BRI1 with Ub negatively regulates BRI1 function and BR signaling, as 
attested by the BR-hypersensitive phenotypes displayed by transgenic plants impaired in 
BRI1 ubiquitination (Fig. 4a, b). BRI1 ubiquitination is however largely independent of 
ligand binding (Fig. 1b, S1b), consistent with previous observations showing that BRI1 
turnover is not modulated by the presence or absence of BRs 13. Surprisingly, BRI1 
ubiquitination required BRI1 kinase activity and the presence of its co-receptor BAK1 (Fig. 
1c), both mechanisms being dependent on BRs. One explanation is that in the absence of 
steroids, BRI1 kinase shows basal kinase activity sufficient for triggering phosphorylation of 
important residues for ubiquitination in BRI1 or another substrate protein, but not involved 
in signaling. The requirement for BAK1 is puzzling considering the BR-dependency of 
BRI1/BAK1 interaction. However, recent evidence based on FRET-FLIM analyses indicates 
that significant proportion of BRI1 and BAK1 interact at the cell surface even in the absence 
of ligand 42. These different observations clarify how BRI1 ubiquitination may rely on 
hallmarks of BR receptor complex activation, although independently of ligand perception. 
The ability of BRI1 to signal from endosome has been highly debated recently. The 
increased plasma membrane localization of BRI1K25R associated to enhanced BR signaling 
confirms recent evidence pointing to the initiation of BR signaling at the cell surface. BRI1 
ubiquitination appears as a mechanism controlling the dynamics of BRI1 in the cell and thus 
impact on BR signaling, although in a BR-independent manner. Whether endogenous/
exogenous cues may impact on BRI1 ubiquitination and thus affect BR-dependent growth 
will have to be investigated in the future.
Altogether, our work identify K63-linked polyubiquitin chain formation as a dual targeting 
signal for BRI1 internalization and sorting along the endocytic pathway, and highlight its 
role in the control of plant development by BR hormones.
Experimental Procedures
Plant material and constructs
Wild-type (Col0), bak1-3 43, bri1 28 and the various transgenic plants generated in this study 
were grown at 21 °C with 16-h light/8-h dark cycles.
BRI1::BRI1-mCitrine, bri1/BRI1::BRI1-mCitrine, bak1-3/BRI1::BRI1-mCitrine and kinase-
dead BRI1::BRI1K911R-mCitrine were previously characterized 28, 36
mCitrine-Ub fusion was cloned into pDONR-P2RP3 (Invitrogen). BRI1K866R and BRI1K25R 
were cloned in pDONR221 (Invitrogen). Final destination vectors were obtained by using 
three fragments recombination system using the pB7m34GW destination vectors 44, and the 
entry vectors pDONR-P4P1r-BRI1prom 28, pDONR221-BRI1 or mutated BRI1 versions, 
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and pDONR-P2rP3-mCitrine 28 or mCitrine-Ub. The constructs were transformed into 
heterozygous bri1 null mutant or wild-type plants. For all constructs, more than 20 
independent T1 lines were isolated and between 3 to 6 representative mono-insertion lines 
were selected in T2. Confocal microscopy, phenotypic analysis and protein extraction were 
performed on segregating T2 and homozygous T3 lines.
Chemical treatments
Inhibitors (Sigma-Aldrich) were used at the following concentrations: 2 μM ConcA (2 mM 
DMSO stock), 50 μM BFA (50 mM DMSO stock), 33 μM TyrA23 (50 mM DMSO stock), 
100μM CHX (100mM EtOH stock). BL (Chemiclones, 1 mM stock in DMSO) and BRZ 
(Chemiclones, 10 mM stock in DMSO) were used at concentrations indicated in the figure 
legends.
Hypocotyl and petiole length assays
Hypocotyl and petiole lengths from 15 seedlings were measured with ImageJ 1.48d on day 4 
and 28, respectively. All dose-response experiments were performed at least in duplicate.
Immunoprecipitation and Western Blot Analysis
Protein extraction and immunoprecipitation experiments were conducted exactly as 
described previously (Jaillais et al., 2011). For protein detection, the following antibodies 
were used: Monoclonal anti-GFP HRP-coupled (Miltenyi Biotech), anti-ubiquitin P4D1 
(Millipore), anti-K63 polyubiquitin Apu3 (Millipore) and anti-BES1 (Yu et al., 2011). 
Quantification of western blot was performed using the Densitometry plugin from Image J 
1.48d.
Mass Spectrometry
Immunopurified proteins were reduced with DTT, alkylated with iodoacetamide and 
digested with trypsin overnight. Salts and reagents were removed by reversed phase (C-18) 
cartridge clean-up. The salt-free peptides were dissolved in 0.1% formic acid and subjected 
to ESI-MS/MS analysis on a Thermo LTQ-Orbitrap XL instrument. A capillary column 
(inner diameter 75 μm, packing length 10 cm of C-18 silica) with integrated spray tip was 
used with a 300 nl/min 0.1% formic acid/acetonitrile gradient. Peptide precursor masses 
were determined with high accuracy by Fourier-transform MS in the Orbitrap followed by 
data dependent MS/MS of the top 5 precursor ions in each chromatographic time window. 
Data were analyzed using the Mascot algorithm (Matrix Science, London, (UK) on a local 
Mascot server (version 2.1.0) and searched against the latest Swiss Protein database 
allowing a variable isopeptide (Gly-Gly) modification on lysine residues.
Model prediction
The kinase domain of BRI1 (residues 867 à 1158) was modeled using the software SWISS-
MODEL (http://swissmodel.expasy.org/) and the interleukin-1 (IL-1) receptor-associated 
kinase-4 (IRAK-4) as template (PDB code 2NRU).
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Confocal microscopy
Plant samples were mounted in water and viewed on Leica TCS SP2 confocal laser scanning 
microscopes. For imaging mCitrine fusion proteins, the 514-nm laser line was used. Laser 
intensity settings were kept constant in individual sets of experiments to allow for a 
comparison of expression and localization of reporter proteins.
TIRF microscopy and analysis of images
Arabidopsis plantlets were grown in MS medium for 5 days in the dark to obtain etiolated 
hypocotyls. Hypocotyls were imaged by TIRF on a Nikon Eclipse Ti microscope equipped 
with a Nikon APO TIRF 100×/1.49 oil immersion objective. The excitation wavelength used 
was 491 nm provided by a 100 mW diode laser Toptica AOTF and emission light was 
collected with an emission filter Chroma ET 525/50. Time-lapses were acquired during 2 
minutes at 200 ms intervals and images were captured with a Photometrics® Evolve Delta 
Camera using the Metamorph Software version 7.7.9.0 (Molecular Devices®, LLC) and the 
laser power at 40%. The videos of 3 independent experiments were then analyzed using the 
ImageJ 1.48d software. To better visualize the videos, the Difference of Gaussian filter and 
the kymographs were obtained on the treated images using the MultiKymographs plugin 
(http://www.embl.de/eamnet/html/body_kymograph.html) of ImageJ. The time of residence 
was determined by the duration of tracks (n=350). To measure the density of BRI1 and 
BRI1K25R at the plasma membrane, videos were treated with the Difference of Gaussian 
filter and the density of protein was quantified by the Find Maxima function within a region 
of same area using ROI manager. Each area measured was 40×41 pixels (0.160μm/pixel) in 
size.
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Figure 1. BRI1 carries K63 polyubiquitin chains in vivo, independently of ligand binding
(a) In vivo ubiquitination analyses of BRI1. Immunoprecipitation was performed using an 
anti-GFP antibody on solubilized protein extracts from wild-type and BRI1-mCitrine plants 
and subjected to immunoblotting with anti-GFP (left), anti-Ub P4D1 (middle) and anti-K63 
polyUb Apu3 (right) antibodies. IB, immunoblotting; IP, immunoprecipitation. (b) Ligand-
dependency of BRI1 ubiquitination. Ubiquitination assays were performed on wild-type and 
BRI1-mCitrine plants treated with mock (−BL) or 1μM BL (+BL) for 1 hour. (C) BRI1 
ubiquitination in mutants affected in receptor complex activation. Ubiquitination assays 
were performed on BRI1-mCitrine, kinase-dead BRI1K911R-mCitrine, and bak1-3/BRI1-
mCitrine plants. The asterisk indicates aspecific signals used as loading control. See also 
Figure S1.
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Figure 2. Artificial ubiquitination of BRI1 triggers vacuolar targeting from TGN/EE
(a) Phenotypic analysis of transgenic plants expressing BRI1-mCitrine, BRI1-mCitrine-Ub 
and BRI1-mCitrine-UbI44A in the bri1 null background. (b) Western blot analyses of BRI1 
protein accumulation in bri1/BRI1-mCitrine, bri1/BRI1-mCitrine-Ub and bri1/BRI1-
mCitrine-UbI44A plants using an anti-GFP antibody. The asterisk indicates aspecific signals 
used as loading control. (c) Confocal microscopy analyses of bri1/BRI1-mCitrine, bri1/
BRI1-mCitrine-Ub and bri1/BRI1-mCitrine-UbI44A roots. Similar detection settings were 
used to compare the different lines. Inset, higher laser power and gain. (d) Drug sensitivity 
of bri1/BRI1-mCitrine and bri1/BRI1-mCitrine-Ub plants. Plants were exposed to BFA 
(50μM) and ConcA (2μM) for 30 minutes and 1 hour, respectively. Similar detection 
settings were used to compare the different lines. See also Figure S2.
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Figure 3. Ubiquitination of residue K866 negatively regulates BRI1
(a) Identification of in vivo ubiquitination sites in BRI1. ED, extracellular domain; PM, 
plasma membrane, ID, intracellular domain; JM, juxtamembrane domain; KD, kinase 
domain; CT, C-terminal domain. The ubiquitinated peptide carrying the GG signature on 
K866 is shown. (b) Western blot analyses on bri1/BRI1-mCitrine and bri1/BRI1K866R-
mCitrine plants. Protein levels were detected with anti-GFP and anti-BES1 antibodies, 
respectively. Quantification of dephosphorylated BES1 protein, normalized to BRI1 levels is 
shown. (c) Phenotypic analysis of 4-week-old bri1/BRI1-mCitrine and bri1/BRI1K866R-
mCitrine plants. (d) Average hypocotyl lengths of 3-day-old etiolated bri1/BRI1-mCitrine 
and bri1/BRI1K866R-mCitrine seedlings (n=15). Error bars indicate standard deviation. (e) 
Confocal microscopy analyses of bri1/BRI1-mCitrine and bri1/BRI1K866R-mCitrine roots. 
See also Figure S3.
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Figure 4. Loss of BRI1 ubiquitination impairs internalization and vacuolar targeting
(a) Phenotypic analysis of 4-week-old bri1/BRI1-mCitrine and bri1/BRI1K25R-mCitrine 
plants. (b) Average petiole lengths of the fourth true leaf from of 4-week-old bri1/BRI1-
mCitrine and bri1/BRI1K25R-mCitrine plants. (c) Western blot analyses on bri1/BRI1-
mCitrine and bri1/BRI1K25R-mCitrine plants using an anti-GFP antibody. The asterisk 
indicates aspecific signals used as loading control. (d) Confocal microscopy analyses of 
bri1/BRI1-mCitrine and bri1/BRI1K25R-mCitrine roots. (e) Sensitivity of bri1/BRI1-
mCitrine and bri1/BRI1K25R-mCitrine plants to BFA. Plants were pretreated with 100μM 
CHX for 1 hour and exposed to 50μM BFA for 30 minutes. (f) Representative kymograph 
obtained from TIRF movies of bri1/BRI1-mCitrine and bri1/BRI1K25R-mCitrine. The time 
scale is shown. (g) Time of residency at the plasma membrane of bri1/BRI1-mCitrine and 
bri1/BRI1K25R-mCitrine. The distribution was obtained from kymograph-based track length 
analyses coming from 3 independent experiments (n=350). (h) Sensitivity of bri1/BRI1-
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mCitrine and bri1/BRI1K25R-mCitrine plants to dark growth conditions. Light-grown 
seedlings were kept in the dark for 2 hours before confocal imaging. See also Figure S4.
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